Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 14 Uveal Melanoma 2 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Basal Cell 2 Urologic Neoplasms 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1 Tertiary Lymphoid Structures 1 Spinocerebellar Degenerations 1 Sarcoma 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Microsatellite Instability 1 Male Urogenital Diseases 1 Locally Advanced Melanoma 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Gastroesophageal Cancer 1

Interventions

relatlimab 1 Ramucirumab 1 Nivolumab 1 Drug Therapy 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gastroesophageal Cancer × relatlimab × Clear all

NCT03610711 2026-05-06

REACTION

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Active not recruiting

Gastrointestinal

Gastroesophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡